Transgenomic Extends Licensing Agreement with Geron

Sep 25, 2003

NEW YORK, Sept. 25 (GenomeWeb News) - Transgenomic will provide an additional supply of modified nucleic acid building-block compounds to Geron, which will use the technology to synthesize one of its thiophosphoramidate-based telomerase inhibitor cancer drugs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Cloud Ready

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

The Science and Policy Connection

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

The New Yeast

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

This Week in Cell

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

Main menu